40 results
Page 2 of 2
8-K
EX-99.1
hp0uduunz d33kz
11 Jan 21
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
a6qacultwl
20 Nov 20
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
4:08pm
8-K
EX-99.1
igmt9fba5xy ngr
12 Nov 20
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:40am
8-K
EX-99.1
04a h807aarhy
17 Aug 20
Stoke Therapeutics Announces Appointment of Garry E. Menzel, Ph.D., to its Board of Directors
7:46am
8-K
EX-99.1
pcqiwe5
10 Aug 20
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:07am
8-K
EX-99.1
5ulw0j0
9 Jul 20
Regulation FD Disclosure
6:06am
8-K
3gf6wvp
9 Jul 20
Regulation FD Disclosure
6:06am
8-K
EX-99.1
5cm80nrp3gbngp anx
15 May 20
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
q446wzwt55khdwr6
12 May 20
Regulation FD Disclosure
10:50am
10-K
tbulho5i8luv
23 Mar 20
Annual report
4:02pm
8-K
EX-99.1
poibt8m
23 Mar 20
STOKE THERAPEUTICS Reports FULL YEAR 2019 financial results and provides business updateS
8:00am
424B4
fezywh51wk
19 Jun 19
Prospectus supplement with pricing info
4:16pm
S-1/A
u0q8mvp b3ahpi
7 Jun 19
IPO registration (amended)
6:08am
S-1
00xpbyh0gcvir29z ko
23 May 19
IPO registration
4:02pm
DRS/A
d0llqmez
30 Apr 19
Draft registration statement (amended)
12:00am
DRS
lz29d3ao6drd
26 Mar 19
Draft registration statement
12:00am